Antibiotice S.A. Logo

Antibiotice S.A.

ATB | RO

Overview

Corporate Details

ISIN(s):
ROATBIACNOR9
LEI:
315700P5G4O1L6GLMS02
Country:
Romania
Address:
VALEA LUPULUI, 707410 IAȘI
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Antibiotice S.A. is a Romanian pharmaceutical company specializing in the research, development, and manufacturing of generic drugs. The company operates eight GMP-certified manufacturing lines, producing a portfolio that includes sterile injectable products and active pharmaceutical ingredients (APIs). It holds U.S. Food and Drug Administration (FDA) approval for key products such as Ampicillin, Nafcillin, and the API Nystatin, demonstrating its commitment to international quality standards. Guided by a mission to make valuable medicines accessible and affordable, Antibiotice serves patients, physicians, and pharmacists in domestic and international markets.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Antibiotice S.A.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-04 12:29
Notice of Dividend Amount
Plata dividend - RC17
Romanian 2.1 MB
2025-08-13 12:27
Pre-Annual General Meeting Information
Convocarea adunarii generale a actionarilor - RC11
Romanian 1.4 MB
2025-08-06 12:40
Report Publication Announcement
Raport curent de informare a investitorilor
Romanian 137.7 KB
2025-07-24 12:07
Pre-Annual General Meeting Information
Convocarea adunarii generale a actionarilor - RC11
Romanian 1.6 MB
2025-07-09 12:28
Board/Management Information
Raport curent de informare a investitorilor
Romanian 491.4 KB
2025-07-01 11:49
Post-Annual General Meeting Information
Raport curent de informare a investitorilor
Romanian 606.7 KB
2025-06-20 14:01
Board/Management Information
Raport curent de informare a investitorilor
Romanian 168.7 KB
2025-06-05 11:06
Regulatory News Service
Raport curent de informare a investitorilor
Romanian 752.7 KB
2025-05-27 15:21
Pre-Annual General Meeting Information
Convocarea adunarii generale a actionarilor - RC11
Romanian 1.4 MB
2025-05-26 12:34
Post-Annual General Meeting Information
Raport curent de informare a investitorilor
Romanian 1.4 MB
2025-05-15 12:05
Post-Annual General Meeting Information
Raport curent de informare a investitorilor
Romanian 749.5 KB
2025-04-23 11:35
Pre-Annual General Meeting Information
Convocarea adunarii generale a actionarilor - RC11
Romanian 1.6 MB
2025-04-22 15:11
Pre-Annual General Meeting Information
Raport curent de informare a investitorilor
Romanian 3.9 MB
2025-03-13 07:54
Notice of Dividend Amount
Raport curent de informare a investitorilor
Romanian 688.4 KB
2025-03-13 07:50
Pre-Annual General Meeting Information
Convocarea adunarii generale a actionarilor - RC11
Romanian 1.4 MB

Automate Your Workflow. Get a real-time feed of all Antibiotice S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Antibiotice S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Genetic Analysis AS Logo
Develops microbiome diagnostics to detect gut dysbiosis for clinical and pharma partners.
Norway GEAN
GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. Logo
Develops and manufactures pharmaceuticals for rare diseases and unmet health needs globally.
Türkiye GENIL
Genomtec S.A. Logo
Develops a mobile platform for rapid, precise genetic diagnostics at the point-of-care.
Poland GMT
Gentian Diagnostics ASA Logo
Develops & manufactures IVD immunoassays for human & veterinary disease diagnostics.
Norway GENT
GlaxoSmithKline PLC Logo
Develops vaccines and specialty medicines for infectious diseases, HIV, oncology, and immunology.
United Kingdom GSK
GNI  Group Ltd. Logo Japan 2160
Gour Medical Logo
Developed veterinary diagnostics and treatments for companion and production animals.
France MLGML
Grifols S.A. Logo
Develops plasma-derived medicines & biopharma solutions for rare and chronic conditions.
Spain GRF
Grindeks Logo
Pharmaceutical company developing and selling original/generic drugs & APIs globally.
Latvia GRD1R
Haemato AG Logo
Manufacturer & wholesaler of specialty pharma for chronic diseases & aesthetics.
Germany HAEK